Home LiteratureArticle Details
PMID: 1259285 Published · ppublish English Comparative Study Journal Article

Chronic respiratory disease in hemp workers. A follow-up study, 1967-1974.

Annals of internal medicine ·Vol. 84 ·No. 4 ·1976-04-00 ·Pages 398-405

Bouhuys A, Zuskin E

Abstract

Many soft-hemp workers with more than 20 years' exposure to dust have chronic respiratory symptoms and obstructive lung function loss. During 7 years of follow-up, these workers had significantly higher occurrences of chronic cough and phlegm and dyspnea than control subjects and a significantly larger annual decline of forced expiratory volume in 1 second (FEV1.0) than control subjects, with a particularly marked difference between 20- to 44-year-old nonsmoking controls and hemp workers. We believe that deterioration of lung function among hemp workers begins before the age of 45 and that it continues even if further exposure to dust ceases. Textile workers should be advised to avoid further exposure to dust at a time when their ventilatory lung function (in the absence of effects of acute exposure) is sufficient to prevent future development of disabling function loss.

MeSH Terms
Adult Age Factors Aged Chronic Disease Environmental Exposure Follow-Up Studies Forced Expiratory Volume Humans Lung Diseases, Obstructive/epidemiology Male Middle Aged Occupational Diseases/epidemiology Respiratory Insufficiency/epidemiology Smoking Spain Textile Industry
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Bouhuys A
Zuskin E
Article Info
Journal
Annals of internal medicine
Abbr.
Ann Intern Med
ISSN
0003-4819
Published
1976-04-00
Pages
398-405
Language
English
Region
United States
NLM ID
0372351
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com